| Morepen Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 500288 |
NSE Symbol : MOREPENLAB |
P/E(TTM) : 33.73 |
|
ISIN Demat : INE083A01026 |
Div & Yield% : - |
EPS(TTM) : 2.37 |
|
Book Value(₹) : 19.87 |
Market Cap(₹Cr) : 4,380.34 |
Face Value(₹) : 2.00 |
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 383.70 | 385.64 | 392.60 | 394.63 | 381.26 | 369.10 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 383.70 | 385.64 | 392.60 | 394.63 | 381.26 | 369.10 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 4.63 | 3.07 | 3.99 | 3.66 | 2.84 | 2.08 |
| Total Income | 388.33 | 388.72 | 396.59 | 398.29 | 384.10 | 371.19 |
| Total Expenditure | 340.64 | 337.03 | 336.46 | 343.52 | 351.50 | 344.30 |
| PBIDT | 47.70 | 51.68 | 60.12 | 54.77 | 32.60 | 26.89 |
| Interest | 1.05 | 1.04 | 0.73 | 2.04 | 0.45 | 0.28 |
| PBDT | 46.65 | 50.64 | 59.39 | 52.73 | 32.14 | 26.61 |
| Depreciation | 3.79 | 3.59 | 6.69 | 5.51 | 4.81 | 4.89 |
| Tax | 10.93 | 12.00 | 13.18 | 12.02 | 7.41 | 5.86 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | -0.44 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | 31.93 | 35.05 | 39.96 | 35.20 | 19.92 | 15.85 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 31.93 | 35.05 | 39.96 | 35.20 | 19.92 | 15.85 |
| EPS (Unit Curr.) | 0.60 | 0.69 | 0.78 | 0.69 | 0.39 | 0.31 |
| EPS (Adj) (Unit Curr.) | 0.60 | 0.69 | 0.78 | 0.69 | 0.39 | 0.31 |
| Calculated EPS (Unit Curr.) | 0.58 | 0.69 | 0.78 | 0.69 | 0.39 | 0.31 |
| Calculated EPS (Adj) (Unit Curr.) | 0.58 | 0.69 | 0.78 | 0.69 | 0.39 | 0.31 |
| Calculated EPS (Ann.) (Unit Curr.) | 2.33 | 2.74 | 3.13 | 2.75 | 1.56 | 1.24 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 2.33 | 2.74 | 3.13 | 2.75 | 1.56 | 1.24 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 109.58 | 102.23 | 102.23 | 102.23 | 102.23 | 102.23 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 12.43 | 13.40 | 15.31 | 13.88 | 8.55 | 7.29 |
| PBDTM(%) | 12.16 | 13.13 | 15.13 | 13.36 | 8.43 | 7.21 |
| PATM(%) | 8.32 | 9.09 | 10.18 | 8.92 | 5.22 | 4.29 |